145 related articles for article (PubMed ID: 31376525)
1. On the relationship of YAP and FAK in hMSCs and osteosarcoma cells: Discrimination of FAK modulation by nuclear YAP depletion or YAP silencing.
Husari A; Steinberg T; Dieterle MP; Prucker O; Rühe J; Jung B; Tomakidi P
Cell Signal; 2019 Nov; 63():109382. PubMed ID: 31376525
[TBL] [Abstract][Full Text] [Related]
2. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
3. FAK, vinculin, and talin control mechanosensitive YAP nuclear localization.
Holland EN; Fernández-Yagüe MA; Zhou DW; O'Neill EB; Woodfolk AU; Mora-Boza A; Fu J; Schlaepfer DD; García AJ
Biomaterials; 2024 Jul; 308():122542. PubMed ID: 38547833
[TBL] [Abstract][Full Text] [Related]
4. FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis.
Lachowski D; Cortes E; Robinson B; Rice A; Rombouts K; Del Río Hernández AE
FASEB J; 2018 Feb; 32(2):1099-1107. PubMed ID: 29070586
[TBL] [Abstract][Full Text] [Related]
5. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer.
Shen J; Cao B; Wang Y; Ma C; Zeng Z; Liu L; Li X; Tao D; Gong J; Xie D
J Exp Clin Cancer Res; 2018 Jul; 37(1):175. PubMed ID: 30055645
[TBL] [Abstract][Full Text] [Related]
6. CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling.
Wang S; Englund E; Kjellman P; Li Z; Ahnlide JK; Rodriguez-Cupello C; Saggioro M; Kanzaki R; Pietras K; Lindgren D; Axelson H; Prinz CN; Swaminathan V; Madsen CD
Nat Cell Biol; 2021 Jul; 23(7):758-770. PubMed ID: 34226698
[TBL] [Abstract][Full Text] [Related]
7. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
[TBL] [Abstract][Full Text] [Related]
8. YAP induces FAK phosphorylation to inhibit gastric cancer cell proliferation via upregulation of HMGB1.
Jiang Y; Fu L; Liu B; Li F
Int J Biol Macromol; 2024 Mar; 262(Pt 1):130037. PubMed ID: 38331059
[TBL] [Abstract][Full Text] [Related]
9. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway.
Kim NG; Gumbiner BM
J Cell Biol; 2015 Aug; 210(3):503-15. PubMed ID: 26216901
[TBL] [Abstract][Full Text] [Related]
10. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
11. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway.
Li Y; Yang S; Yang S
Cells; 2022 Apr; 11(8):. PubMed ID: 35456040
[TBL] [Abstract][Full Text] [Related]
12. Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines.
Ferraiuolo M; Pulito C; Finch-Edmondson M; Korita E; Maidecchi A; Donzelli S; Muti P; Serra M; Sudol M; Strano S; Blandino G
Cancer Lett; 2018 Oct; 433():18-32. PubMed ID: 29933048
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of FOXD1 by YAP alleviates senescence and osteoarthritis.
Fu L; Hu Y; Song M; Liu Z; Zhang W; Yu FX; Wu J; Wang S; Izpisua Belmonte JC; Chan P; Qu J; Tang F; Liu GH
PLoS Biol; 2019 Apr; 17(4):e3000201. PubMed ID: 30933975
[TBL] [Abstract][Full Text] [Related]
14. Targeting YAP in malignant pleural mesothelioma.
Zhang WQ; Dai YY; Hsu PC; Wang H; Cheng L; Yang YL; Wang YC; Xu ZD; Liu S; Chan G; Hu B; Li H; Jablons DM; You L
J Cell Mol Med; 2017 Nov; 21(11):2663-2676. PubMed ID: 28470935
[TBL] [Abstract][Full Text] [Related]
15. YAP/TEAD3 signal mediates cardiac lineage commitment of human-induced pluripotent stem cells.
Han Z; Yu Y; Cai B; Xu Z; Bao Z; Zhang Y; Bamba D; Ma W; Gao X; Yuan Y; Zhang L; Yu M; Liu S; Yan G; Jin M; Huang Q; Wang X; Hua B; Yang F; Pan Z; Liang H; Liu Y
J Cell Physiol; 2020 Mar; 235(3):2753-2760. PubMed ID: 31541452
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance.
Uchihara T; Miyake K; Yonemura A; Komohara Y; Itoyama R; Koiwa M; Yasuda T; Arima K; Harada K; Eto K; Hayashi H; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Yashiro M; Masuda M; Ajani JA; Tan P; Baba H; Ishimoto T
Cancer Res; 2020 Aug; 80(16):3222-3235. PubMed ID: 32605995
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
[TBL] [Abstract][Full Text] [Related]
18. Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity.
Kishi T; Mayanagi T; Iwabuchi S; Akasaka T; Sobue K
Oncotarget; 2016 Nov; 7(44):72113-72130. PubMed ID: 27708220
[TBL] [Abstract][Full Text] [Related]
19. MiR-33a Controls hMSCS Osteoblast Commitment Modulating the Yap/Taz Expression Through EGFR Signaling Regulation.
Costa V; Carina V; Raimondi L; De Luca A; Bellavia D; Conigliaro A; Salamanna F; Alessandro R; Fini M; Giavaresi G
Cells; 2019 Nov; 8(12):. PubMed ID: 31771093
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway.
He Y; Zou P; Lu Y; Jia D; Li X; Yang H; Tang L; Zhu Z; Tu T; Tai S; Xiao Y; Chen M; Lu L; Zhou S
J Mol Cell Cardiol; 2020 Feb; 139():1-13. PubMed ID: 31958462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
